FIELD: biotechnology.
SUBSTANCE: invention relates, in particular, to methods for isolation of bacterial lipopolysaccharides and can be used for preparing chemical vaccines, immunomodulating agents and for construction of diagnostic test-systems. Extraction of lipopolysaccharides is carried out with buffer solution containing EDTA in the concentration 0.01-0.05 mmole per 1 g of wetted cells, 0.1 mmole of phenylmethylsulfonyl chloride and 1% of Triton X-100. Prepared extract is separated from microorganisms by centrifugation and subjected for treatment with enzyme proteinase K. Invention provides significant simplifying method for preparing lipopolysaccharides and to improve quality of the end preparation.
EFFECT: improved preparing method.
1 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD TO PRODUCE LYPOPOLYSACCHARIDE OF PLAGUE AGENT | 2012 |
|
RU2483112C1 |
| STRAIN OF Escherichia coli BACTERIA - PRODUCENT OF HEAT SHOCK PROTEIN 70 AND METHOD FOR OBTAINING PREPARATION OF HUMAN HEAT SHOCK PROTEIN | 2013 |
|
RU2564120C2 |
| METHOD TO PRODUCE PROTEIN E7-HSP70 AND YEAST STRAIN Saccharomyces cerevisiae FOR ITS REALISATION | 2012 |
|
RU2489481C1 |
| POLYMER FRAGMENT OF PEPTIDOGLICAN OF GRAM-NEGATIVE BACTERIA CELL WALL, METHOD OF ITS OBTAINING AND ITS APPLICATION AS IMMUNOSTIMULATOR | 2006 |
|
RU2412197C2 |
| METHOD FOR PRODUCTION OF PLASMID DNA FROM BACTERIAL CELLS | 2009 |
|
RU2408729C2 |
| METHOD FOR DETECTING BACTERIA OF GENUS AZOSPIRILLUM, WHICH HAVE COMMON ANTIGENIC DETERMINANTS IN COMPOSITION OF LIPOPOLYSACCHARIDES | 2013 |
|
RU2572350C2 |
| METHOD FOR PREPARING MELIODOSIS PATHOGEN CAPSULE SUBSTANCE | 2001 |
|
RU2231364C2 |
| RECOMBINANT PLASMID DNA pET21-IFN- γ, CONTAINING GENE CODING HUMAN GAMMA-INTERFERON, ESCHERICHIA COLI BL21/pET21-IFN-γ STRAIN - PRODUCER OF HUMAN RECOMBINANT GAMMA-INTERFERON AND METHOD OF PRODUCING HUMAN GAMMA-INTERFERON | 2023 |
|
RU2827613C1 |
| DIAGNOSTICUM FOR IDENTIFICATION OF ESCHERICHIA COLI 0157:H7 AND METHOD OF ITS PREPARING | 2001 |
|
RU2189253C1 |
| METHOD FOR ISOLATION OF BIOACTIVE FRACTION (BAF) CONTAINING S-LIPOPOLYSACCHARIDES (S-LPS) FROM GRAM-NEGATIVE BACTERIA, BAF FOR PREVENTION AND TREATMENT OF DISEASES INDUCED BY ENDOTOXIC S-LPS PRODUCING GRAM-NEGATIVE BACTERIA, PHARMACEUTICAL COMPOSITION, METHODS FOR INDUCING OF PROTECTIVE IMMUNITY AND IMPROVING STATE IN PATIENT IN NEED OF IMMUNE STATUS INCREASING | 2002 |
|
RU2260053C2 |
